Cabot Corporation CBT | NYSE

$78.42 $1.20 | 1.55%

Next Earnings: May 05, 2025

Company Overview:

Market Cap: $4.25B
PE Ratio: 10.44
52-Week Range: $73.63 - $117.46
Dividend Yield (FWD): 2.23% ($1.72)

6.3 Year Performance Metrics:

Total Return (with DRIP): 92.81% (10.98% / yr)
Total Return (no DRIP): 84.67% (10.23% / yr)
Share Price: 64.68%
Dividend Increase: 30.30
CBT 6.3-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

CBT Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
CBT Dividend CAGR:1Y: 7.50%2Y: 7.80%5Y: 4.20%10Y: 6.93%
Share Price
CBT Price CAGR:1Y: -16.03%2Y: 4.35%5Y: 19.39%10Y: 5.12%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

CBT Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - CBT
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - CBT
14-Day FREE Trial Get Full Access Now!

CBT Earnings, Revenue, Cash & Debt, Shares Outstaning:

CBT - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
CBT - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CBT - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CBT - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
CBT - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
CBT - Cash & Debt
14-Day FREE Trial Get Full Access Now!
CBT - Revenue
14-Day FREE Trial Get Full Access Now!
CBT Revenue CAGR:1Y: -0.31%2Y: -0.52%5Y: 5.61%10Y: 1.64%
CBT - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
CBT EPS CAGR:1Y: 92.05%2Y: 34.80%5Y: 19.28%10Y: 9.37%
CBT - Net Income
14-Day FREE Trial Get Full Access Now!
CBT Net Income CAGR:1Y: 86.00%2Y: 31.23%5Y: 17.80%10Y: 7.53%
CBT - EBITDA
14-Day FREE Trial Get Full Access Now!
CBT EBITDA CAGR:1Y: 25.95%2Y: 17.56%5Y: 14.08%10Y: 6.20%
CBT - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
CBT Free Cash Flow CAGR:1Y: -7.84%2Y: 66.27%5Y: 4.90%10Y: 12.10%
CBT - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
CBT Free Cash Flow / Share CAGR:1Y: -6.15%2Y: 69.31%5Y: 5.89%10Y: 13.89%
CBT - Gross Profit
14-Day FREE Trial Get Full Access Now!
CBT Gross Profit CAGR:1Y: 7.80%2Y: 13.94%5Y: 10.76%10Y: 4.12%
CBT - Expenses
14-Day FREE Trial Get Full Access Now!
CBT Expenses CAGR:1Y: 42.59%2Y: 48.32%5Y: 2.52%10Y: 6.51%
CBT - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
CBT Shares Outstanding CAGR:1Y: -1.43%2Y: -1.51%5Y: -0.71%10Y: -1.60%
CBT - Share Buybacks
14-Day FREE Trial Get Full Access Now!
CBT Share Buybacks CAGR:1Y: 27.27%2Y: 57.18%5Y: 4.32%10Y: -1.12%
CBT - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
CBT Stock-Based Comp CAGR:1Y: 33.33%2Y: 15.47%5Y: 51.57%10Y: 7.18%
CBT - Dividends
14-Day FREE Trial Get Full Access Now!
CBT Dividend CAGR:1Y: 7.50%2Y: 7.80%5Y: 4.20%10Y: 6.93%
CBT - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
CBT Revenue CAGR:1Y: -0.31%2Y: -0.52%5Y: 5.61%10Y: 1.64%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

CBT - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CBT Actual Revenue CAGR:1Y: -0.31%2Y: -0.52%5Y: 5.61%10Y: 1.64%
CBT - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CBT Actual EPS CAGR:1Y: 92.05%2Y: 34.80%5Y: 19.28%10Y: 9.37%
CBT - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CBT Actual Net Income CAGR:1Y: 86.00%2Y: 31.23%5Y: 17.80%10Y: 7.53%
CBT - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CBT Actual EBITDA CAGR:1Y: 25.95%2Y: 17.56%5Y: 14.08%10Y: 6.20%

Ratios, Profit Margins & Return on Capital:

CBT - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
CBT Net Profit Margin CAGR:1Y: 86.59%2Y: 31.88%5Y: 11.55%10Y: 5.80%
CBT - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
CBT Gross Profit Margin CAGR:1Y: 8.13%2Y: 14.54%5Y: 4.88%10Y: 2.44%
CBT - Price to Earnings
14-Day FREE Trial Get Full Access Now!
CBT - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
CBT - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
CBT - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

CBT Dividends Info:

Annual Dividend: $1.72
Forward Yield: 2.19%
Ex-Dividend Date: 2025-02-28
Lifetime Dividens / Share: $41.68

CBT Dividend History: Dates, Payments & Yield list

Below is a schedule of all CBT dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
02/28/202503/14/2025$0.4302%2%$86.00
11/29/202412/13/2024$0.4301.54%1.57%$109.62
08/30/202409/13/2024$0.4301.58%1.64%$105.11
05/31/202406/14/2024$0.4301.59%1.68%$102.30
02/22/202403/08/2024$0.4001.94%1.94%$82.61
11/22/202312/08/2023$0.4002.03%2.07%$77.32
08/24/202309/08/2023$0.4002.22%2.31%$69.24
05/25/202306/09/2023$0.4002.16%2.29%$69.75
02/23/202303/10/2023$0.3701.89%1.89%$78.12
11/23/202212/09/2022$0.3702.01%2.01%$73.80
08/25/202209/09/2022$0.3701.91%1.91%$77.46
05/26/202206/10/2022$0.3702.02%2.04%$72.39
02/24/202203/11/2022$0.3702%2.05%$72.10
11/24/202112/10/2021$0.3702.43%2.54%$58.34
08/26/202109/10/2021$0.3502.65%2.65%$52.83
05/27/202106/11/2021$0.3502.21%2.21%$63.37
02/25/202103/12/2021$0.3502.81%2.81%$49.80
11/25/202012/11/2020$0.3503.21%3.21%$43.59
08/27/202009/11/2020$0.3503.68%3.68%$38.00
05/28/202006/12/2020$0.3503.83%3.83%$36.53
02/27/202003/13/2020$0.3503.79%3.79%$36.94
11/27/201912/13/2019$0.3502.9%2.94%$47.64
08/29/201909/13/2019$0.3503.45%3.55%$39.47
05/30/201906/14/2019$0.3503.27%3.42%$40.93
02/21/201903/08/2019$0.3302.83%2.83%$46.59
11/29/201812/14/2018$0.3300%0%$0.00
08/30/201809/14/2018$0.3300%0%$0.00
05/24/201806/08/2018$0.3300%0%$0.00
02/22/201803/09/2018$0.3150%0%$0.00
11/22/201712/08/2017$0.3150%0%$0.00
08/23/201709/08/2017$0.3150%0%$0.00
05/24/201706/09/2017$0.3150%0%$0.00
02/22/201703/10/2017$0.3000%0%$0.00
11/22/201612/09/2016$0.3000%0%$0.00
08/24/201609/09/2016$0.3000%0%$0.00
05/25/201606/10/2016$0.3000%0%$0.00
02/24/201603/11/2016$0.2200%0%$0.00
11/24/201512/11/2015$0.2200%0%$0.00
08/26/201509/11/2015$0.2200%0%$0.00
05/27/201506/12/2015$0.2200%0%$0.00
02/25/201503/13/2015$0.2200%0%$0.00
11/25/201412/12/2014$0.2200%0%$0.00
08/27/201409/12/2014$0.2200%0%$0.00
05/28/201406/13/2014$0.2200%0%$0.00
02/26/201403/14/2014$0.2000%0%$0.00
11/26/201312/13/2013$0.2000%0%$0.00
08/28/201309/13/2013$0.2000%0%$0.00
05/29/201306/14/2013$0.2000%0%$0.00
02/27/201303/15/2013$0.2000%0%$0.00
11/28/201212/14/2012$0.2000%0%$0.00
08/29/201209/14/2012$0.2000%0%$0.00
05/30/201206/15/2012$0.2000%0%$0.00
02/22/201203/09/2012$0.1800%0%$0.00
11/22/201112/09/2011$0.1800%0%$0.00
08/25/201109/09/2011$0.1800%0%$0.00
05/25/201106/10/2011$0.1800%0%$0.00
02/23/201103/11/2011$0.1800%0%$0.00
11/23/201012/10/2010$0.1800%0%$0.00
08/25/201009/10/2010$0.1800%0%$0.00
05/26/201006/11/2010$0.1800%0%$0.00
02/24/201003/12/2010$0.1800%0%$0.00
11/24/200912/11/2009$0.1800%0%$0.00
08/26/200909/11/2009$0.1800%0%$0.00
05/27/200906/12/2009$0.1800%0%$0.00
02/25/200903/13/2009$0.1800%0%$0.00
11/25/200812/12/2008$0.1800%0%$0.00
08/27/200809/12/2008$0.1800%0%$0.00
05/28/200806/13/2008$0.1800%0%$0.00
02/27/200803/14/2008$0.1800%0%$0.00
11/28/200712/14/2007$0.1800%0%$0.00
08/29/200709/14/2007$0.1800%0%$0.00
05/23/200706/08/2007$0.1800%0%$0.00
02/21/200703/09/2007$0.1800%0%$0.00
11/21/200612/08/2006$0.1800%0%$0.00
08/23/200609/08/2006$0.1600%0%$0.00
05/24/200606/09/2006$0.1600%0%$0.00
02/22/200603/10/2006$0.1600%0%$0.00
11/22/200512/09/2005$0.1600%0%$0.00
08/24/200509/09/2005$0.1600%0%$0.00
05/25/200506/10/2005$0.1600%0%$0.00
02/23/200503/11/2005$0.1600%0%$0.00
11/23/200412/10/2004$0.1600%0%$0.00
08/25/200409/10/2004$0.1500%0%$0.00
05/26/200406/11/2004$0.1500%0%$0.00
02/25/200403/12/2004$0.1500%0%$0.00
11/25/200312/12/2003$0.1500%0%$0.00
08/27/200309/12/2003$0.1500%0%$0.00
05/28/200306/13/2003$0.1300%0%$0.00
02/26/200303/14/2003$0.1300%0%$0.00
11/26/200212/13/2002$0.1300%0%$0.00
08/28/200209/13/2002$0.1300%0%$0.00
05/29/200206/14/2002$0.1300%0%$0.00
02/20/200203/08/2002$0.1300%0%$0.00
11/28/200112/14/2001$0.1300%0%$0.00
08/29/200109/14/2001$0.1300%0%$0.00
05/23/200106/08/2001$0.1300%0%$0.00
02/21/200103/09/2001$0.1100%0%$0.00
11/21/200012/08/2000$0.1100%0%$0.00
10/02/200010/04/2000$13.4630%0%$0.00
08/23/200009/08/2000$0.1100%0%$0.00
05/24/200006/09/2000$0.1100%0%$0.00
02/23/200003/10/2000$0.1100%0%$0.00
11/23/199912/10/1999$0.1100%0%$0.00
08/25/199909/10/1999$0.1100%0%$0.00
05/26/199906/11/1999$0.1100%0%$0.00
02/24/199903/12/1999$0.1100%0%$0.00
11/24/199812/11/1998$0.1100%0%$0.00
08/26/199809/11/1998$0.1100%0%$0.00
05/27/199806/12/1998$0.1100%0%$0.00
02/25/199803/13/1998$0.1000%0%$0.00
11/25/199712/12/1997$0.1000%0%$0.00
08/27/199709/12/1997$0.1000%0%$0.00
05/28/199706/13/1997$0.1000%0%$0.00
02/26/199703/14/1997$0.1000%0%$0.00
11/20/199612/06/1996$0.1000%0%$0.00
08/21/199609/06/1996$0.0900%0%$0.00
05/22/199606/07/1996$0.0900%0%$0.00
11/21/199512/08/1995$0.0900%0%$0.00
08/23/199509/08/1995$0.0900%0%$0.00
05/22/199506/09/1995$0.0700%0%$0.00
02/17/199503/10/1995$0.0700%0%$0.00
11/18/199412/09/1994$0.0700%0%$0.00
08/22/199409/09/1994$0.0700%0%$0.00
05/23/199406/10/1994$0.0650%0%$0.00
02/18/199403/11/1994$0.0650%0%$0.00
11/19/199312/10/1993$0.0650%0%$0.00
08/23/199309/10/1993$0.0650%0%$0.00
05/24/199306/11/1993$0.0650%0%$0.00
02/22/199303/12/1993$0.0650%0%$0.00
11/20/199212/11/1992$0.0650%0%$0.00
08/17/199209/04/1992$0.0650%0%$0.00
05/18/199206/05/1992$0.0650%0%$0.00
02/24/199203/13/1992$0.0650%0%$0.00
11/18/199112/06/1991$0.0650%0%$0.00
08/19/199109/06/1991$0.0650%0%$0.00
05/20/199106/07/1991$0.0650%0%$0.00
04/09/199104/11/1991$0.3170%0%$0.00
02/12/199103/08/1991$0.0650%0%$0.00
11/16/199012/07/1990$0.0650%0%$0.00
08/20/199009/07/1990$0.0650%0%$0.00
05/21/199006/08/1990$0.0650%0%$0.00
02/16/199003/09/1990$0.0650%0%$0.00
11/17/198912/08/1989$0.0650%0%$0.00
08/21/198909/08/1989$0.0650%0%$0.00
05/22/198906/09/1989$0.0650%0%$0.00
02/17/198903/10/1989$0.0650%0%$0.00
11/21/198812/12/1988$0.0580%0%$0.00
08/23/198809/12/1988$0.0580%0%$0.00
05/24/198806/13/1988$0.0580%0%$0.00
02/19/198803/11/1988$0.0580%0%$0.00
11/27/198701/05/1988$0.0580%0%$0.00
11/26/198601/05/1987$0.0580%0%$0.00
08/13/198608/15/1986$0.0580%0%$0.00
05/21/198605/23/1986$0.0580%0%$0.00
02/20/198602/24/1986$0.0580%0%$0.00
11/26/198511/28/1985$0.0580%0%$0.00

Projected Future Returns & Dividends for CBT

Based on past 6.3-year performance, here are CBT growth metrics:

Share price CAGR of +8.24%
Dividend CAGR of +6.93%

Using CBT CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

CBT (DRIP)CBT - No DRIP
Current Price$77.22$77.22
Start Shares129.50129.50
Start Value$10,000$10,000
  
After 10 years:
Final Share Count159.83129.50
Dividends Payment$0.84$0.84
Annual Dividends$537$435
Yield on cost5.37%4.35%
Share Price$157.48$157.48
Total Dividends$3,452$3,068
Final Value$25,171$23,461

Estimated Future Value + Dividends - CBT

NOTE: Above numbers are our estimate based on CBT's Dividend and Price CAGR over past 6.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Cabot Corporation (CBT) had its IPO on 1980-11-05, and is trader on NYSE stock exchange.

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.

CBT website: https://www.cabotcorp.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial